ATE272646T1 - Herstellung von kristallinen form ii von clarithromycin - Google Patents

Herstellung von kristallinen form ii von clarithromycin

Info

Publication number
ATE272646T1
ATE272646T1 AT97934319T AT97934319T ATE272646T1 AT E272646 T1 ATE272646 T1 AT E272646T1 AT 97934319 T AT97934319 T AT 97934319T AT 97934319 T AT97934319 T AT 97934319T AT E272646 T1 ATE272646 T1 AT E272646T1
Authority
AT
Austria
Prior art keywords
methylerythromycin
alkyl
solvent
halo
nitro
Prior art date
Application number
AT97934319T
Other languages
English (en)
Inventor
Jih-Hua Liu
David A Riley
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27102712&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE272646(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/681,695 external-priority patent/US5844105A/en
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE272646T1 publication Critical patent/ATE272646T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT97934319T 1996-07-29 1997-07-28 Herstellung von kristallinen form ii von clarithromycin ATE272646T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/681,695 US5844105A (en) 1996-07-29 1996-07-29 Preparation of crystal form II of clarithromycin
US90027197A 1997-07-25 1997-07-25
PCT/US1997/013166 WO1998004574A1 (en) 1996-07-29 1997-07-28 Preparation of crystal form ii of clarithromycin

Publications (1)

Publication Number Publication Date
ATE272646T1 true ATE272646T1 (de) 2004-08-15

Family

ID=27102712

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97934319T ATE272646T1 (de) 1996-07-29 1997-07-28 Herstellung von kristallinen form ii von clarithromycin

Country Status (12)

Country Link
EP (1) EP0915899B1 (de)
JP (4) JP4104660B2 (de)
KR (1) KR100524214B1 (de)
AT (1) ATE272646T1 (de)
AU (1) AU733646B2 (de)
CA (1) CA2261732C (de)
DE (3) DE97934319T1 (de)
DK (1) DK0915899T3 (de)
ES (1) ES2173057T3 (de)
IL (1) IL127833A (de)
PT (1) PT915899E (de)
WO (1) WO1998004574A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5945405A (en) * 1997-01-17 1999-08-31 Abbott Laboratories Crystal form O of clarithromycin
CA2245398C (en) 1998-08-21 2002-01-29 Apotex Inc. Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof
KR100377159B1 (ko) * 1998-09-09 2003-08-19 한미약품공업 주식회사 잔류 용매가 없는 클라리스로마이신의 결정형 2의 제조 방법
GB9827355D0 (en) * 1998-12-11 1999-02-03 Biochemie Sa Organic compounds
KR20010008496A (ko) * 1999-07-01 2001-02-05 유충식 6-오-메틸 에리트로마이신의 제조방법
KR100322313B1 (ko) * 1999-10-21 2002-02-06 민경윤 클라리스로마이신 결정형 2의 제조방법 및 이에 사용되는 클라리스로마이신 포르메이트
US6627743B1 (en) 1999-12-03 2003-09-30 Abbott Laboratories 6-O-methylerythromycin A crystal form III
IL150227A0 (en) * 1999-12-16 2002-12-01 Teva Pharma Processes for preparing clarithromycin polymorphs and novel polymorph iv
AU2261901A (en) * 2000-01-11 2001-07-24 Teva Pharma Processes for preparing clarithromycin polymorphs
EP1313486A1 (de) 2000-02-29 2003-05-28 Teva Pharmaceutical Industries Ltd. Verfahren zur herstellung des clarithromycins und eines clarithromycin-zwischenprodukt; clarithromycin wesentlich frei von oxime; und pharmazeutische zusammensetzung die sie enthalten
BR0109194A (pt) 2000-03-15 2003-02-11 Hanmi Pharm Ind Co Ltd Método para preparar claritromicina em cristais da forma ii
KR100367981B1 (ko) * 2000-11-23 2003-01-14 한미약품공업 주식회사 클라리스로마이신 결정형 2의 제조 방법 및 이 방법에사용되는 결정성 클라리스로마이신 메실레이트 삼수화물
KR100361397B1 (ko) * 2000-03-15 2002-11-23 한미약품공업 주식회사 에리스로마이신 에이 9-오-트로필옥심 유도체를 이용한클라리스로마이신의 제조방법
KR100408848B1 (ko) * 2001-03-12 2003-12-06 주식회사 씨트리 클래리스로마이신의 정제방법
US6861413B2 (en) 2001-05-22 2005-03-01 Pfizer Inc. Stable non-dihydrate azithromycin oral suspensions
SI1390377T1 (sl) * 2001-05-22 2006-06-30 Pfizer Prod Inc Nova kristalna oblika azitromicina
EE200300575A (et) 2001-05-22 2004-04-15 Pfizer Products Inc. Asitromütsiini kristalsed vormid
KR100372254B1 (en) * 2002-07-15 2003-02-19 Korea United Pharm Inc Erythromycin a 9-o-pseudosaccharinyl oxime derivative and process for preparing clarithromycin using the same
AU2003271408B2 (en) * 2002-12-31 2008-07-17 Alembic Limited A process for the purification of roxithromycin
US7384921B2 (en) * 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
EP2104680B1 (de) * 2006-12-05 2013-01-09 Bristol-Myers Squibb Company Motilid-polymorphe
DE102007016367A1 (de) 2007-04-03 2008-10-09 Grünenthal GmbH Polymorph von Clarithromycin (Form V)
CN103087130B (zh) * 2013-02-06 2015-12-23 浙江国邦药业有限公司 一种克拉霉素晶型转换方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5782400A (en) 1980-11-12 1982-05-22 Taisho Pharmaceut Co Ltd Erythromycin derivative
JPS572298A (en) * 1980-06-04 1982-01-07 Taisho Pharmaceut Co Ltd Erythromycin derivative
US4331803A (en) 1980-06-04 1982-05-25 Taisho Pharmaceutical Co., Ltd. Novel erythromycin compounds
JPS60214796A (ja) 1984-04-06 1985-10-28 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシン類の製法
JPS61103890A (ja) 1984-10-26 1986-05-22 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシンａ誘導体
US4670549A (en) * 1985-03-18 1987-06-02 Taisho Pharmaceutical Co., Ltd. Method for selective methylation of erythromycin a derivatives
EP0260938B1 (de) 1986-09-18 1992-12-09 Taisho Pharmaceutical Co. Ltd Erythromycin-A-Derivate und Verfahren zu ihrer Herstellung
JPH0755958B2 (ja) * 1986-10-03 1995-06-14 大正製薬株式会社 エリスロマイシンａ誘導体の製造方法
JP2526951B2 (ja) * 1986-12-17 1996-08-21 大正製薬株式会社 エリスロマイシンａ誘導体およびその製造方法
KR960000434B1 (ko) * 1986-12-17 1996-01-06 다이쇼 세이야꾸 가부시끼가이샤 에리스로마이신 a유도체 및 그의 제조 방법
JP2782793B2 (ja) * 1988-06-15 1998-08-06 大正製薬株式会社 エリスロマイシンａ誘導体およびその製造方法
ZA922777B (en) * 1991-04-29 1993-10-15 Lilly Co Eli Pharmaceutical formulation containing dirithromycin
US5872229A (en) * 1995-11-21 1999-02-16 Abbott Laboratories Process for 6-O-alkylation of erythromycin derivatives
US5719272A (en) 1996-04-02 1998-02-17 Abbott Laboratories 2'-protected 3'-dimethylamine, 9-etheroxime erythromycin A derivatives
US5837829A (en) 1996-04-02 1998-11-17 Abbott Laboratories 9-oximesilyl erythromycin a derivatives

Also Published As

Publication number Publication date
DE97934319T1 (de) 2004-08-26
DE69730138T2 (de) 2005-03-03
JP2002514171A (ja) 2002-05-14
WO1998004574A1 (en) 1998-02-05
JP4104660B2 (ja) 2008-06-18
AU3740597A (en) 1998-02-20
AU733646B2 (en) 2001-05-17
IL127833A (en) 2004-06-20
DE29724846U1 (de) 2004-12-16
KR20000029591A (ko) 2000-05-25
JP2006137765A (ja) 2006-06-01
ES2173057T1 (es) 2002-10-16
PT915899E (pt) 2004-11-30
CA2261732A1 (en) 1998-02-05
JP2009242411A (ja) 2009-10-22
DK0915899T3 (da) 2004-11-29
KR100524214B1 (ko) 2005-11-01
ES2173057T3 (es) 2004-11-16
EP0915899A1 (de) 1999-05-19
EP0915899B1 (de) 2004-08-04
DE69730138D1 (de) 2004-09-30
JP2013151542A (ja) 2013-08-08
CA2261732C (en) 2001-07-24
IL127833A0 (en) 1999-10-28

Similar Documents

Publication Publication Date Title
ATE272646T1 (de) Herstellung von kristallinen form ii von clarithromycin
DK196586A (da) Makrolidantibiotika
KR850007434A (ko) 에리트로마이신a 유도체의 선택적 메틸화 방법
AU598204B2 (en) Chemical derivatives of antibiotics S541
AR039666A2 (es) Procedimiento para la preparacion de la forma i de 6-o-metileritromicina a al vacio, dicho compuesto cristalino aislado asi como sus derivados, el uso de los mismos para la preparacion de un antibiotico, el uso de la forma 0 para prepararla forma i de 6-o-metileritromicina a y otros derivados
AU4923379A (en) Alkyl derivatives of c-076 compounds
AU3172893A (en) 5-O-desosaminylerythronolide derivatives
KR910019996A (ko) 시클로헥센온 옥심 에테르, 그것의 제조방법 및 제초제로서의 이용
ES8506011A1 (es) Procedimiento para la obtencion de un derivado de tetrahidrobenzotiazol
KR930007880A (ko) 비스(페닐)에탄 유도체
DE3165998D1 (de) Indole and indoline derivatives
HRP980496B1 (en) New thilozine hydroxy derivatives and a process for the preparation thereof
KR930010014A (ko) 기론다론 화합물 및 그의 제조방법
ATE377605T1 (de) 6-oxygenierte steroid-estrogene mit aromatischen a- und b-ringen
EP0997457A4 (de) 3-benzoylindol-derivate und sie enthaltende medikamente
KR950026860A (ko) 4-히드록시 피라졸을 함유한 프로페노익 에스테르 유도체
KR950000702A (ko) 결정성 β- 락탐 일수화물의 제조방법
KR890005099A (ko) 결정상 항생제 중간물질
IE801888L (en) Trans-fused decahydroquinolinol derivatives
JPS54154739A (en) Reducing agents
KR940009168A (ko) 신규의 제리쿠드라닌 화합물 및 그의 제조방법
JPS53108981A (en) Thioisocarbostyril derivative and its preparation
KR970014569A (ko) 치환된 아미노기를 갖는 신규 티아졸에톡시퀴나졸린 유도체, 그의 제조방법 및 그를 유효성분으로 하는 식물 병원균 퇴치용 농약 조성물
JPS5517343A (en) Repellent against wild animal
DE69808673D1 (de) Zinn-polyoxaalkancarboxylaten, und diese enthaltende zusammensetzungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0915899

Country of ref document: EP